Han, S.; Kim, Y.-H.; Lee, M.-Y.; Bang, O.Y.; Jang, S.-W.; Han, S.; Park, Y.-J.; Kang, S.; On, Y.K.; Suh, H.S.
Impact of Reduced-Dose Nonvitamin K Antagonist Oral Anticoagulants on Outcomes Compared to Warfarin in Korean Patients with Atrial Fibrillation: A Nationwide Population-Based Study. J. Clin. Med. 2021, 10, 3918.
https://doi.org/10.3390/jcm10173918
AMA Style
Han S, Kim Y-H, Lee M-Y, Bang OY, Jang S-W, Han S, Park Y-J, Kang S, On YK, Suh HS.
Impact of Reduced-Dose Nonvitamin K Antagonist Oral Anticoagulants on Outcomes Compared to Warfarin in Korean Patients with Atrial Fibrillation: A Nationwide Population-Based Study. Journal of Clinical Medicine. 2021; 10(17):3918.
https://doi.org/10.3390/jcm10173918
Chicago/Turabian Style
Han, Sola, Young-Hoon Kim, Myung-Yong Lee, Oh Young Bang, Sung-Won Jang, Seongwook Han, Yoo-Jung Park, Seongsik Kang, Young Keun On, and Hae Sun Suh.
2021. "Impact of Reduced-Dose Nonvitamin K Antagonist Oral Anticoagulants on Outcomes Compared to Warfarin in Korean Patients with Atrial Fibrillation: A Nationwide Population-Based Study" Journal of Clinical Medicine 10, no. 17: 3918.
https://doi.org/10.3390/jcm10173918
APA Style
Han, S., Kim, Y.-H., Lee, M.-Y., Bang, O. Y., Jang, S.-W., Han, S., Park, Y.-J., Kang, S., On, Y. K., & Suh, H. S.
(2021). Impact of Reduced-Dose Nonvitamin K Antagonist Oral Anticoagulants on Outcomes Compared to Warfarin in Korean Patients with Atrial Fibrillation: A Nationwide Population-Based Study. Journal of Clinical Medicine, 10(17), 3918.
https://doi.org/10.3390/jcm10173918
